Free Trial

Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume

$15.42
+0.04 (+0.26%)
(As of 07/26/2024 ET)

Abrdn Life Sciences Investors Short Interest Data

Current Short Interest
5,200 shares
Previous Short Interest
16,100 shares
Change Vs. Previous Month
-67.70%
Dollar Volume Sold Short
$79,456.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 15, 2024
Outstanding Shares
27,350,000 shares
Percentage of Shares Shorted
0.02%
Today's Trading Volume
79,751 shares
Average Trading Volume
105,033 shares
Today's Volume Vs. Average
76%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Abrdn Life Sciences Investors ?

Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HQL Short Interest Over Time

HQL Days to Cover Over Time

HQL Percentage of Float Shorted Over Time

Abrdn Life Sciences Investors Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20245,200 shares $79,456.00 -67.7%N/A0.1 $15.28
6/30/202416,100 shares $228,137.00 +67.7%N/A0.2 $14.17
6/15/20249,600 shares $132,671.04 -72.4%N/A0.1 $13.82
5/31/202434,800 shares $463,536.00 -52.7%N/A0.4 $13.32
5/15/202473,600 shares $1.05 million +26.0%N/A0.9 $14.27
4/30/202458,400 shares $765,624.00 +205.8%N/A0.6 $13.11
4/15/202419,100 shares $247,918.00 -10.3%N/A0.2 $12.98
3/31/202421,300 shares $290,319.00 -27.6%N/A0.2 $13.63
3/15/202429,400 shares $396,900.00 -47.5%N/A0.2 $13.50
2/29/202456,000 shares $767,200.00 -58.0%N/A0.4 $13.70
2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05
1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72
1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16
12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46
12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15
11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94
11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04
10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59
10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28
9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47
9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83
8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01
8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42
7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45
7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41
6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55
6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84
5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29
5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06
4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93
4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03
3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93
3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72
2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96
2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63
1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94
1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76
12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21
12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72
11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08
I’m giving you the name of this investment for free (Ad)

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video
11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05
10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65
10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79
9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66
9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80
8/31/202220,100 shares $290,244.00 +55.8%N/A0.3 $14.44
8/15/202212,900 shares $210,399.00 +79.2%N/A0.2 $16.31
7/31/20227,200 shares $107,424.00 -77.1%N/A0.1 $14.92
7/15/202231,400 shares $475,082.00 +91.5%N/A0.4 $15.13
6/30/202216,400 shares $233,372.00 +11.6%N/A0.2 $14.23
6/15/202214,700 shares $198,156.00 +110.0%N/A0.2 $13.48
5/31/20227,000 shares $101,990.00 -84.6%N/A0.1 $14.57
5/15/202245,400 shares $653,760.00 -30.5%N/A0.6 $14.40
4/30/202265,300 shares $1.01 million +262.8%N/A0.9 $15.49
4/15/202218,000 shares $303,660.00 -1.1%N/A0.2 $16.87
3/31/202218,200 shares $301,028.00 -55.6%N/A0.2 $16.54
3/15/202241,000 shares $637,550.00 -67.6%N/A0.4 $15.55
2/28/2022126,600 shares $2.09 million -36.0%N/A1.4 $16.47
2/15/2022197,700 shares $3.48 million -18.6%N/A2.1 $17.61
1/31/2022243,000 shares $4.41 million +130.6%N/A2.8 $18.15
1/15/2022105,400 shares $1.96 million +626.9%N/A1.2 $18.56
12/31/202114,500 shares $278,835.00 -85.8%N/A0.2 $19.23
12/15/2021102,200 shares $1.95 million -5.0%N/A1.5 $19.10
11/30/2021107,600 shares $2.13 million -29.9%N/A1.7 $19.84
11/15/2021153,400 shares $3.15 million -0.5%N/A2.5 $20.54
10/29/2021154,100 shares $3.28 million +553.0%N/A2.2 $21.27
10/15/202123,600 shares $487,576.00 +34.9%N/A0.3 $20.66
9/30/202117,500 shares $364,000.00 -61.8%N/A0.3 $20.80
9/15/202145,800 shares $996,608.00 +70.3%N/A0.7 $21.76
8/31/202126,900 shares $587,765.00 -40.5%N/A0.4 $21.85
8/13/202145,200 shares $980,840.00 +396.7%N/A0.6 $21.70
7/30/20219,100 shares $189,280.00 +37.9%N/A0.1 $20.80
7/15/20216,600 shares $135,894.00 -85.5%N/A0.1 $20.59
6/30/202145,500 shares $975,520.00 +792.2%N/A0.6 $21.44
6/15/20215,100 shares $106,335.00 -88.5%N/A0.1 $20.85
5/28/202144,400 shares $884,892.00 -5.7%N/A0.5 $19.93
5/14/202147,100 shares $901,494.00 -12.9%N/A0.5 $19.14
4/30/202154,100 shares $1.10 million +12.0%N/A0.6 $20.34
4/15/202148,300 shares $951,993.00 -60.5%N/A0.6 $19.71
3/31/2021122,300 shares $2.39 million +38.7%N/A1.4 $19.51
3/15/202188,200 shares $1.78 million -23.8%N/A1.1 $20.23
2/26/2021115,700 shares $2.43 million +105.9%N/A1.4 $21.00
2/12/202156,200 shares $1.23 million +561.2%N/A0.7 $21.85
1/29/20218,500 shares $171,785.00 -76.7%N/A0.1 $20.21
1/15/202136,400 shares $744,016.00 -25.3%N/A0.5 $20.44
12/31/202048,700 shares $963,773.00 +549.3%N/A0.6 $19.79
12/15/20207,500 shares $145,200.00 -86.4%N/A0.1 $19.36
11/30/202055,000 shares $1.03 million +63.7%N/A0.7 $18.73
11/15/202033,600 shares $612,864.00 -19.2%N/A0.4 $18.24
10/30/202041,600 shares $715,104.00 +222.5%N/A0.5 $17.19
I’m giving you the name of this investment for free (Ad)

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video
10/15/202012,900 shares $236,844.00 -18.4%N/A0 $18.36
9/30/202015,800 shares $277,764.00 -81.4%N/A0.2 $17.58
9/15/202011,000 shares $196,350.00 -87.1%N/A0.1 $17.85
8/31/202085,000 shares $1.52 million +135.5%N/A1 $17.83
8/14/202036,100 shares $646,190.00 -37.4%N/A0.4 $17.90
7/31/202057,700 shares $1.03 million +262.9%N/A0.6 $17.91
7/15/202015,900 shares $293,832.00 +40.7%N/A0.2 $18.48
6/30/202011,300 shares $199,332.00 -65.7%N/A0.1 $17.64
6/15/202032,900 shares $567,854.00 -9.6%N/A0.3 $17.26
5/29/202036,400 shares $642,460.00 +318.4%N/A0.3 $17.65
5/15/20208,700 shares $150,945.00 -71.8%N/A0.1 $17.35
4/30/202030,800 shares $528,836.00 +13.7%N/A0.2 $17.17
4/15/202027,100 shares $437,394.00 +88.2%N/A0.2 $16.14
3/31/202014,400 shares $250,128.00 +251.2%N/A0.1 $17.37
3/13/20204,100 shares $64,288.00 -87.4%0.0%0 $15.68
2/28/202032,400 shares $403,056.00 +356.3%N/A0.3 $12.44
2/14/20207,100 shares $112,109.00 -57.2%N/A0.1 $15.79
1/31/202016,600 shares $284,856.00 -5.1%N/A0.2 $17.16
1/15/202017,500 shares $311,500.00 +25.9%N/A0.2 $17.80
12/31/201913,900 shares $237,551.00 -35.1%N/A0.1 $17.09

HQL Short Interest - Frequently Asked Questions

What is Abrdn Life Sciences Investors' current short interest?

Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 5,200 shares of HQL short. Learn More on Abrdn Life Sciences Investors' current short interest.

Is Abrdn Life Sciences Investors' short interest increasing or decreasing?

Abrdn Life Sciences Investors saw a drop in short interest in July. As of July 15th, there was short interest totaling 5,200 shares, a drop of 67.7% from the previous total of 16,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Abrdn Life Sciences Investors' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "investment offices, not elsewhere classified" compare to Abrdn Life Sciences Investors: The Gabelli Equity Trust Inc. (0.05%), General American Investors Company, Inc. (0.04%), Nuveen Nasdaq 100 Dynamic Overwrite Fund (0.04%), BlackRock MuniHoldings California Quality Fund, Inc. (0.15%), MidCap Financial Investment Co. (1.53%), Abrdn Healthcare Investors (0.01%), BlackRock MuniYield Quality Fund, Inc. (0.11%), SLR Investment Corp. (0.24%), BlackRock MuniYield Quality Fund III, Inc. (0.11%), PIMCO High Income Fund (0.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short Abrdn Life Sciences Investors stock?

Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abrdn Life Sciences Investors?

A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further.

How often is Abrdn Life Sciences Investors' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is July, 15 2024.



This page (NYSE:HQL) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners